1. Home
  2. SIDU vs SGMO Comparison

SIDU vs SGMO Comparison

Compare SIDU & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$4.37

Market Cap

151.0M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.28

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
SGMO
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.0M
141.2M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
SIDU
SGMO
Price
$4.37
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.00
AVG Volume (30 Days)
28.4M
6.6M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
66.94
10.20
EPS
N/A
N/A
Revenue
$3,383,878.00
$36,567,000.00
Revenue This Year
$171.29
$24.46
Revenue Next Year
N/A
$193.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
88.60
52 Week Low
$0.63
$0.21
52 Week High
$5.99
$0.84

Technical Indicators

Market Signals
Indicator
SIDU
SGMO
Relative Strength Index (RSI) 56.46 42.07
Support Level $0.89 $0.21
Resistance Level $4.40 $0.55
Average True Range (ATR) 0.83 0.03
MACD 0.16 0.00
Stochastic Oscillator 59.02 65.19

Price Performance

Historical Comparison
SIDU
SGMO

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: